MKI67 and breast carcinoma: Recently, the proliferative rate assessed by Ki-67 in tumor cells has gained increasing importance in prognostication and stratification of various cancers such as breast cancer [5], lymphoma and neuroendocrine neoplasia [6, 7], however, Ki-67 has shown to be of limited use in GC [8].